RPB researchers are working to understand and prevent macular degeneration, to halt its progression, and to develop optical devices to offset vision loss. Each year, RPB dedicates hundreds of thousands of dollars to AMD research.
This ground-breaking research accomplishment will open new doors for research on neurodegenerative diseases like AMD.
RPB grantees provide expert insight on geographic atrophy and dry AMD as part of the "Lunch & Learn" series.
Join RPB and Apellis Pharmaceuticals for a virtual event on Feb. 25 to learn about cutting-edge research into geographic atrophy and dry AMD.
RPB grantees provide expert advice on dry AMD as part of the "Lunch & Learn" series.
RPB grantees provide expert advice on AMD as part of the "Lunch & Learn" series.
Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.